
About Orchev Pharma
Orchev Pharma is a Healthcare company based in Rajkot (India) founded in 1989. It manufactures high-quality pharmaceutical APIs and intermediates for global exports. It operates on a B2B model. The company has 28 employees. Its Indian entity Orchev Pharma Pvt Ltd reported revenue of βΉ59.72 Cr. Orchev Pharma offers products and services including Famotidine, Ranitidine, Telmisartan, Levetiracetam, and Allopurinol. Its focus areas include Pharmaceuticals, API Manufacturing, Drug Intermediates and Active Ingredients. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Orchev Pharma Pvt. Ltd., established in 1989 in Gujarat, India, specializes in manufacturing active pharmaceutical ingredients such as Ranitidine, Famotidine, Telmisartan, and Levetiracetam. The company operates under strict standards like USFDA and WHO-GMP, focusing on quality assurance, research, and exports to international markets. It provides services including contract manufacturing and trial supplies, serving global clients through B2B relationships.
- Headquarters Rajkot, India
- Employees 28
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website orchev.com
- Social LinkedIn
- Legal Name Orchev Pharma Pvt Ltd
- Date of Incorporation 28 Jun, 1989
- Jurisdiction Rajkot, Gujarat, India
- Annual Revenue₹59.72 Cr
FY 2026 · +37% YoY
- Net Profit₹40.7 Lakh
FY 2026 · 1% margin
- EBITDA₹1.69 Cr
FY 2026 · 3% margin
- Employee Count28
Associated legal entities of Orchev Pharma
Orchev Pharma operates through Orchev Pharma Pvt Ltd (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Orchev Pharma Pvt Ltd CIN U24231GJ1989PTC012430 | Active | 28 Jun 1989 | Rajkot, Gujarat | ₹59.7 Cr | 43 | 4 | View details |
Products & Services of Orchev Pharma
Orchev Pharma offers a comprehensive portfolio of products and services, including Famotidine, Ranitidine, Telmisartan, Levetiracetam, and Allopurinol.
Active ingredient used for treating acid-related disorders.
Active ingredient for gastric acid reduction therapy.
Active ingredient for managing high blood pressure.
Active ingredient for treating epilepsy seizures.
Active ingredient for gout and kidney stone prevention.
Board of directors of Orchev Pharma Pvt Ltd (Orchev Pharma)
Orchev Pharma Pvt Ltd is the primary company behind Orchev Pharma. The board of Orchev Pharma Pvt Ltd currently have 4 directors; the longest-serving is Vasantlal Odhavjibhai Bhalodia, appointed in 1989. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vasantlal Odhavjibhai Bhalodia DIN 00544069 | Managing Director | 28 Jun 1989 | 37 yrs 4 mo | Orchev Pharma Pvt Ltd |
| Kanchanben Vasantlal Bhalodia DIN 00544082 | Director | 03 Oct 1992 | 34 yrs 1 mo | Orchev Pharma Pvt Ltd |
| Viren Vasant Patel DIN 00544034 | Director | 01 Jun 2006 | 20 yrs 5 mo | Orchev Pharma Pvt Ltd |
| Chirag Vasantbhai Patel DIN 00544051 | Director | 01 Aug 2006 | 20 yrs 3 mo | Orchev Pharma Pvt Ltd |
Financials of Orchev Pharma
Figures of Orchev Pharma Pvt Ltd, the primary company behind Orchev Pharma, for FY 2026. Revenue was ₹59.72 Cr (+37% year on year). Net profit was ₹40.7 Lakh (1% margin). EBITDA was ₹1.69 Cr (3% margin). Revenue has grown at a compounded annual rate of +21% over three years and +29% over five years.
- ₹59.72 CrRevenue · FY 2026 · +37% YoY
- ₹40.7 LakhNet profit · 1% margin
- ₹1.69 CrEBITDA · 3% margin
- ₹99.9 LakhPaid-up capital
- 43Employees (provident fund records)
- +21%Revenue CAGR, 3 years
- +29%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Orchev Pharma Pvt Ltd are on its company page.
Detailed financial statements for Orchev Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Orchev Pharma
Orchev Pharma has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Orchev Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Orchev Pharma
Orchev Pharma was founded in 1989.
Orchev Pharma is headquartered in Rajkot, India. It is registered at Rajkot, Gujarat, India.
Orchev Pharma has 28 employees.
The primary company behind Orchev Pharma, Orchev Pharma Pvt Ltd, reported revenue of βΉ59.72 Cr for FY 2026, up 37% year on year.
Orchev Pharma Pvt. Ltd., established in 1989 in Gujarat, India, specializes in manufacturing active pharmaceutical ingredients such as Ranitidine, Famotidine, Telmisartan, and Levetiracetam. The company operates under strict standards like USFDA and WHO-GMP, focusing on quality assurance, research, and exports to international markets. It provides services including contract manufacturing and trial supplies, serving global clients through B2B relationships.
Orchev Pharma's top competitors include Laurus Labs, Symbiotec and SeQuent.
Orchev Pharma offers Famotidine, Ranitidine, Telmisartan, Levetiracetam, and Allopurinol.
Orchev Pharma operates through Orchev Pharma Pvt Ltd.
The legal entities of Orchev Pharma currently have 4 directors, including Chirag Vasantbhai Patel, Vasantlal Odhavjibhai Bhalodia, Viren Vasant Patel and others.